Tranexamic acid to prevent bleeding in repeat c-section
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial is for women having their second or third planned c-section. It tests if giving a medicine called tranexamic acid helps prevent heavy bleeding. The medicine is safe and commonly used to reduce bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are pregnant with one baby and at least 37 weeks along.
- This is your second or third planned c-section (not your first).
- You are at low risk for heavy bleeding after delivery.
- You can read and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study tests if giving tranexamic acid (a medicine that helps blood clot) before C-section can reduce bleeding during and after surgery. It may help women who have higher risks of bleeding during delivery.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
Hear when a new Cesarean Delivery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.